1. Home
  2. CNTX vs ILLR Comparison

CNTX vs ILLR Comparison

Compare CNTX & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • ILLR
  • Stock Information
  • Founded
  • CNTX 2015
  • ILLR 2015
  • Country
  • CNTX United States
  • ILLR United States
  • Employees
  • CNTX N/A
  • ILLR N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • ILLR Investment Managers
  • Sector
  • CNTX Health Care
  • ILLR Finance
  • Exchange
  • CNTX Nasdaq
  • ILLR Nasdaq
  • Market Cap
  • CNTX 78.0M
  • ILLR 79.7M
  • IPO Year
  • CNTX 2021
  • ILLR N/A
  • Fundamental
  • Price
  • CNTX $0.79
  • ILLR $0.45
  • Analyst Decision
  • CNTX Strong Buy
  • ILLR
  • Analyst Count
  • CNTX 5
  • ILLR 0
  • Target Price
  • CNTX $5.25
  • ILLR N/A
  • AVG Volume (30 Days)
  • CNTX 145.6K
  • ILLR 339.4K
  • Earning Date
  • CNTX 08-06-2025
  • ILLR 08-26-2025
  • Dividend Yield
  • CNTX N/A
  • ILLR N/A
  • EPS Growth
  • CNTX N/A
  • ILLR N/A
  • EPS
  • CNTX N/A
  • ILLR N/A
  • Revenue
  • CNTX N/A
  • ILLR $45,244,000.00
  • Revenue This Year
  • CNTX N/A
  • ILLR N/A
  • Revenue Next Year
  • CNTX N/A
  • ILLR N/A
  • P/E Ratio
  • CNTX N/A
  • ILLR N/A
  • Revenue Growth
  • CNTX N/A
  • ILLR N/A
  • 52 Week Low
  • CNTX $0.49
  • ILLR $0.40
  • 52 Week High
  • CNTX $2.70
  • ILLR $6.52
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 58.08
  • ILLR N/A
  • Support Level
  • CNTX $0.68
  • ILLR N/A
  • Resistance Level
  • CNTX $0.73
  • ILLR N/A
  • Average True Range (ATR)
  • CNTX 0.05
  • ILLR 0.00
  • MACD
  • CNTX -0.00
  • ILLR 0.00
  • Stochastic Oscillator
  • CNTX 55.65
  • ILLR 0.00

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About ILLR Triller Group Inc. Common Stock

Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.

Share on Social Networks: